Back | Next |
home / stock / meip / meip message board
Subject | By | Source | When |
---|---|---|---|
Out @.589, lol that was quick.. ill keep | DD-214 | investorshub | 03/28/2022 4:24:34 PM |
Took a new position on $MEIP, 50k @.593 average. | DD-214 | investorshub | 03/28/2022 2:50:10 PM |
$MEIP $MEIP roadrunner goes off the cliff. | willlbone | investorshub | 03/25/2022 5:43:54 PM |
The price is better | stockweiser | investorshub | 03/25/2022 4:17:32 PM |
Ouch, 25% loss in less than a day | ErnieBilco | investorshub | 03/25/2022 2:41:51 PM |
Bid 50 cents | willlbone | investorshub | 03/25/2022 2:19:13 PM |
Well, Let's see how my .98s work out | ErnieBilco | investorshub | 03/24/2022 11:03:18 PM |
znewcar1: MEIP 37% v26,7M c3.37 f112M H3.55 | znewcar1 | investorshangout | 11/30/2021 10:20:19 PM |
znewcar1: MEIP 37% v26,7M c3.37 f112M H3.55 | znewcar1 | investorshangout | 11/30/2021 10:03:11 PM |
whytestocks: $MEIP News Article - MEI Pharma Announces Inducement Grant under Nasdaq Listing Rule 56 | whytestocks | investorshangout | 07/01/2021 8:10:47 PM |
whytestocks: $MEIP News Article - MEI Pharma and Kyowa Kirin Announce Completion of Patient Enrollme | whytestocks | investorshangout | 04/13/2021 6:20:51 PM |
whytestocks: $MEIP News Article - MEI Pharma Announces Expansion of Phase 1b Study Evaluating Zandel | whytestocks | investorshangout | 01/04/2021 7:55:47 PM |
Tipranks added them as one of their top | doczaius | investorshub | 08/17/2020 4:33:43 PM |
I am continuing to buy at these prices. | Aarin | investorshub | 07/29/2020 2:24:01 PM |
Back in at $3.02. I have a | Aarin | investorshub | 07/23/2020 8:02:33 PM |
This is a pretty big deal for me. | Aarin | investorshub | 07/02/2020 3:10:30 PM |
$MEIP & partner Helsinn announce discontinuation of Phase | bladerunner1717 | investorshub | 07/02/2020 2:00:56 PM |
WATCH for possible breakout above 4.36, no resistance | realfast95 | investorshub | 06/23/2020 6:12:28 PM |
something is brewing, large blocks today | realfast95 | investorshub | 06/22/2020 7:47:05 PM |
whytestocks: $MEIP great article | whytestocks | investorshangout | 04/22/2020 7:10:44 PM |
News, Short Squeeze, Breakout and More Instantly...
-- Ongoing Phase 1 Study Evaluating Voruciclib Plus Venetoclax Demonstrates Anti-leukemic Activity, Including Complete Responses, Anticipated Decreases in Mcl-1 and No Overlapping Toxicity in Heavily Pretreated R/R AML Patients -- -- Board of Directors Unanimously Aligned on Prioritizatio...
– MEI Pharma Board Unanimously Determines, Based on Clinical Data Results, Not to Proceed with Second Capital Return Under 2023 Anson and Cable Car Cooperation Agreement: Conserving Capital, Prioritizing Measured Investment, Extending Operational Runway – MEI Pharma, Inc. ...
– Cohort 1 Exceeds Predetermined Non-Progression Threshold in the Ongoing Phase 1b Study – – ME-344 in Combination with Bevacizumab was Generally Well-tolerated with no Evidence of Overlapping Toxicity – – MEI to Continue Advancing ME-344 via Dev...